{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T07:46:48Z","timestamp":1770277608627,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T00:00:00Z","timestamp":1684281600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T00:00:00Z","timestamp":1684281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s12098-023-04584-y","type":"journal-article","created":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T01:01:46Z","timestamp":1684285306000},"page":"811-816","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["World Health Organization Guideline on the Management of Tuberculosis in Children: Critical Appraisal, Concerns, and Caution"],"prefix":"10.1007","volume":"90","author":[{"given":"Ketan","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2866-2623","authenticated-orcid":false,"given":"Joseph L.","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,17]]},"reference":[{"key":"4584_CR1","unstructured":"World Health Organization. WHO Consolidated Guidelines on Tuberculosis: Module 5: Management of Tuberculosis in Children and Adolescents [Internet]. Available at: https:\/\/www.who.int\/publications\/i\/item\/9789240046764. Accessed on 10th Oct 2022."},{"key":"4584_CR2","unstructured":"World Health Organization. Guidance for National Tuberculosis Programmes on the Management of Tuberculosis in Children, 2nd ed [Internet]. Available at: https:\/\/www.who.int\/publications\/i\/item\/9789241548748. Accessed on 10th Oct 2022."},{"key":"4584_CR3","unstructured":"World Health Organization. WHO Consolidated Guidelines on Tuberculosis. Module 3: Diagnosis - Rapid Diagnostics for Tuberculosis Detection, 2021 Update. Available at: https:\/\/www.who.int\/publications\/i\/item\/9789240029415. Accessed on 10th Oct 2022."},{"key":"4584_CR4","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s12098-019-03001-7","volume":"86","author":"V Singh","year":"2019","unstructured":"Singh V. Pediatric TB Management under RNTCP: what and why? Indian J Pediatr. 2019;86:707\u201313.","journal-title":"Indian J Pediatr"},{"key":"4584_CR5","first-page":"CD013359","volume":"8","author":"AW Kay","year":"2020","unstructured":"Kay AW, Gonz\u00e1lez Fern\u00e1ndez L, Takwoingi Y, et al. Xpert MTB\/RIF and Xpert MTB\/RIF Ultra assays for active tuberculosis and rifampicin resistance in children. Cochrane Database Syst Rev. 2020;8:CD013359.","journal-title":"Cochrane Database Syst Rev"},{"key":"4584_CR6","doi-asserted-by":"publisher","first-page":"e00812","DOI":"10.1128\/mBio.00812-17","volume":"8","author":"S Chakravorty","year":"2017","unstructured":"Chakravorty S, Simmons AM, Rowneki M, et al. The New Xpert MTB\/RIF Ultra: improving detection of mycobacterium tuberculosis and resistance to rifampin in an assay suitable for point-of-care testing. mBio. 2017;8:e00812\u201317.","journal-title":"mBio"},{"key":"4584_CR7","doi-asserted-by":"crossref","unstructured":"Jaganath D, Wambi P, Reza TF, et al. A prospective evaluation of Xpert MTB\/RIF Ultra for Childhood Pulmonary Tuberculosis in Uganda. J Pediatr Infect Dis Soc. 2021;10:586\u201392.","DOI":"10.1093\/jpids\/piaa159"},{"key":"4584_CR8","doi-asserted-by":"publisher","first-page":"e00410","DOI":"10.1128\/JCM.00410-20","volume":"58","author":"W Ssengooba","year":"2020","unstructured":"Ssengooba W, Iragena JD, Nakiyingi L, et al. Accuracy of Xpert ultra in diagnosis of pulmonary tuberculosis among children in uganda: a substudy from the SHINE Trial. J Clin Microbiol. 2020;58:e00410\u201320.","journal-title":"J Clin Microbiol"},{"key":"4584_CR9","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1093\/cid\/ciaa583","volume":"73","author":"S Kabir","year":"2021","unstructured":"Kabir S, Rahman SMM, Ahmed S, et al. Xpert Ultra assay on stool to diagnose pulmonary tuberculosis in children. Clin Infect Dis. 2021;73:226\u201334.","journal-title":"Clin Infect Dis"},{"key":"4584_CR10","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jinf.2020.10.036","volume":"82","author":"XH Liu","year":"2021","unstructured":"Liu XH, Xia L, Song B, et al. Stool-based Xpert MTB\/RIF ultra assay as a tool for detecting pulmonary tuberculosis in children with abnormal chest imaging: a prospective cohort study. J Infect. 2021;82:84\u20139.","journal-title":"J Infect"},{"key":"4584_CR11","unstructured":"The Union\u2019s desk guide for diagnosis and management of TB in children. Third edition, 2016. Paris: International Union Against Tuberculosis and Lung Disease; 2016. Available at: https:\/\/theunion.org\/sites\/default\/files\/2020-08\/2016_Desk-guide_Africa_Web.pdf. Accessed on 23rd Jan 2023."},{"key":"4584_CR12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/cid\/civ581","volume":"61","author":"SM Graham","year":"2015","unstructured":"Graham SM, Cuevas LE, Jean-Philippe P, et al. Clinical case definitions for classification of intrathoracic tuberculosis in children: an update. Clin Infect Dis. 2015;61:179\u201387.","journal-title":"Clin Infect Dis"},{"key":"4584_CR13","unstructured":"World Health Organization. WHO Consolidated Guidelines on Tuberculosis: Module 5: Management of Tuberculosis in Children and Adolescents: Web Annex 3. GRADE Evidence to Decision Tables. Available at: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/352509\/9789240046801-eng.pdf. Accessed on 23rd Jan 2023."},{"key":"4584_CR14","unstructured":"World Health Organization. WHO Operational Handbook on Tuberculosis: Module 5: Management of Tuberculosis in Children and Adolescents [Internet]. Available at: https:\/\/www.who.int\/publications\/i\/item\/9789240046832. Accessed on 10th Dec 2022."},{"key":"4584_CR15","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1056\/NEJMoa2104535","volume":"386","author":"A Turkova","year":"2022","unstructured":"Turkova A, Wills GH, Wobudeya E, et al. Shorter treatment for nonsevere tuberculosis in African and indian children. N Engl J Med. 2022;386:911\u201322.","journal-title":"N Engl J Med"},{"key":"4584_CR16","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1136\/bmj.38049.490255.DE","volume":"328","author":"G Agarwal","year":"2004","unstructured":"Agarwal G, Awasthi S, Kabra SK, et al. Three day versus five day treatment with amoxicillin for non-severe pneumonia in young children: a multicentre randomised controlled trial. BMJ. 2004;328:791.","journal-title":"BMJ"},{"key":"4584_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa1912400","volume":"383","author":"AS Ginsburg","year":"2020","unstructured":"Ginsburg AS, Mvalo T, Nkwopara E, et al. Amoxicillin for 3 or 5 days for chest-indrawing pneumonia in malawian children. N Engl J Med. 2020;383:13\u201323.","journal-title":"N Engl J Med"},{"key":"4584_CR18","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/S0140-6736(02)09994-4","volume":"360","author":"Pakistan Multicentre Amoxycillin Short Course Therapy (MASCOT) pneumonia study group","year":"2002","unstructured":"Pakistan Multicentre Amoxycillin Short Course Therapy (MASCOT) pneumonia study group. Clinical efficacy of 3 days versus 5 days of oral amoxicillin for treatment of childhood pneumonia: a multicentre double-blind trial. Lancet. 2002;360:835\u201341.","journal-title":"Lancet"},{"key":"4584_CR19","unstructured":"Department of Health, Republic of South Africa. Guidelines for the management of tuberculosis in children. Pretoria, South Africa: Department of Health; 2013. Available at: https:\/\/www.knowledgehub.org.za\/system\/files\/elibdownloads\/2020-04\/National-Childhood-TB-Guidelines-2013-ZA.pdf. Accessed on 23rd Dec 2022."},{"key":"4584_CR20","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.tube.2010.07.003","volume":"90","author":"PR Donald","year":"2010","unstructured":"Donald PR. The chemotherapy of tuberculous meningitis in children and adults. Tuberculosis (Edinb). 2010;90:375\u201392.","journal-title":"Tuberculosis (Edinb)"},{"key":"4584_CR21","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1186\/s12879-016-1923-2","volume":"16","author":"ND Bang","year":"2016","unstructured":"Bang ND, Caws M, Truc TT, et al. Clinical presentations, diagnosis, mortality and prognostic markers of tuberculous meningitis in vietnamese children: a prospective descriptive study. BMC Infect Dis. 2016;16:573.","journal-title":"BMC Infect Dis"},{"key":"4584_CR22","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1542\/peds.2008-1353","volume":"123","author":"GT van Well","year":"2009","unstructured":"van Well GT, Paes BF, Terwee CB, et al. Twenty years of pediatric tuberculous meningitis: a retrospective cohort study in the western cape of South Africa. Pediatrics. 2009;123:e1\u20138.","journal-title":"Pediatrics"},{"key":"4584_CR23","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/INF.0000000000000065","volume":"33","author":"R van Toorn","year":"2014","unstructured":"van Toorn R, Schaaf HS, Laubscher JA, van Elsland SL, Donald PR, Schoeman JF. Short intensified treatment in children with drug-susceptible tuberculous meningitis. Pediatr Infect Dis J. 2014;33:248\u201352.","journal-title":"Pediatr Infect Dis J"},{"key":"4584_CR24","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/cid\/ciab982","volume":"75","author":"S Thee","year":"2022","unstructured":"Thee S, Basu Roy R, Bl\u00e1zquez-Gamero D, et al. Treatment and outcome in children with tuberculous meningitis: a multicenter pediatric tuberculosis network european trials group study. Clin Infect Dis. 2022;75:372\u201381.","journal-title":"Clin Infect Dis"},{"key":"4584_CR25","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.ijtb.2017.03.001","volume":"64","author":"R Gupta","year":"2017","unstructured":"Gupta R, Kushwaha S, Thakur R, et al. Predictors of adverse outcome in patients of tuberculous meningitis in a multi-centric study from India. Indian J Tuberc. 2017;64:296\u2013301.","journal-title":"Indian J Tuberc"},{"key":"4584_CR26","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1177\/0883073816668112","volume":"31","author":"SR Dhawan","year":"2016","unstructured":"Dhawan SR, Gupta A, Singhi P, Sankhyan N, Malhi P, Khandelwal N. Predictors of neurological outcome of tuberculous meningitis in childhood: a prospective cohort study from a developing country. J Child Neurol. 2016;31:1622\u20137.","journal-title":"J Child Neurol"},{"key":"4584_CR27","unstructured":"World Health Organization. WHO Consolidated Guidelines on Tuberculosis: Module 5: Management of Tuberculosis in Children and Adolescents: Web Annex 4. Summaries of Unpublished Studies. Available at: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/352510\/9789240046818-eng.pdf. Accessed on 22nd Dec 2022."}],"container-title":["Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-023-04584-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12098-023-04584-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-023-04584-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T14:53:45Z","timestamp":1689864825000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12098-023-04584-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,17]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["4584"],"URL":"https:\/\/doi.org\/10.1007\/s12098-023-04584-y","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,17]]},"assertion":[{"value":"7 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}